effects [qlco]
Oral [spco]
transdermal estrogen [horm, phsu, strd]
Progesterone [horm, phsu, strd]
regimens [inpr]
Blood [tisu]
Coagulation [ortf]
Fibrinolysis [phsf]
postmenopausal [tmco]
Women [popg]
randomized [resa]
Controlled [ftcn]
Trial [resa]
Hormone Replacement Therapy, Post-Menopausal [topp]
Associated [qlco]
reduction [npop]
Incidence [qnco]
coronary heart disease [dsyn]
Inconclusive [idcn]
Result [ftcn]
Reported [inpr]
Risk [qlco]
Stroke [dsyn]
Recent [tmco]
studies [lbpr]
Show [inpr]
Increased [qnco]
Risk [qlco]
Venous Thromboembolism [patf]
postmenopausal [tmco]
Women [popg]
Using [ftcn]
Oral [spco]
Estrogen [horm, phsu, strd]
Interventional Study [resa]
Assess [acty]
True [qlco]
effects [qlco]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
regimens [inpr]
Blood coagulation [ortf]
Fibrinolysis [phsf]
IMPACT [gngm]
ROUTE [ftcn]
Estrogen [horm, phsu, strd]
Administration [ocac]
Haemostasis [ortf]
Not [ftcn]
Well [qlco]
Documented [hlca]
investigated [ftcn]
effects [qlco]
Oral [spco]
Transdermal [ftcn]
Estradiol / Progesterone [phsu]
Replacement therapy [topp]
haemostatic [ortf]
variables [qlco]
Five [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Aged [orga]
Assigned [ftcn]
One [qnco]
Three [qnco]
Following [tmco]
Group [idcn]
Cyclic [tmco]
Oral [spco]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Combined [qlco]
Progesterone [horm, phsu, strd]
Hormonal [qlco]
treatment [ftcn]
haemostatic [ortf]
variables [qlco]
Assay [lbpr]
baseline [bodm]
month [tmco]
Mean [qnco]
Change [ftcn]
Three [qnco]
Group [idcn]
Compared [acty]
Using [ftcn]
Non-Parametric Test [inpr]
Oral [spco]
Not [ftcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Regimen [topp]
Increased [qnco]
Mean [qnco]
Value [qnco]
Prothrombin [aapp, bacs, phsu]
Activation [acty]
Peptide [aapp]
Decreased Activity [sosy]
Mean [qnco]
Antithrombin [aapp, phsu]
Compared [acty]
treatment [ftcn]
fragment [ftcn]
Levels [qlco]
Active Treatment [topp]
Oral [spco]
Estrogen [horm, phsu, strd]
Group [idcn]
Associated [qlco]
Decrease [qlco]
Mean [qnco]
tissue type [lbpr]
Plasminogen [aapp, bacs, phsu]
Concentration [menp]
plasminogen activator activity [moft]
Inhibitor [qlco]
Global [spco]
fibrinolytic [topp]
Capacity [qnco]
Compared [acty]
Two [qnco]
Group [idcn]
transdermal estrogen [horm, phsu, strd]
Regimen [topp]
Effect [qlco]
Plasminogen activator inhibitor [aapp, bacs]
Type [qlco]
Plasminogen [aapp, bacs, phsu]
Global [spco]
fibrinolytic [topp]
Capacity [qnco]
Levels [qlco]
Mean [qnco]
Values [qlco]
Fibrinogen [aapp, bacs, phsu]
Factor VII [aapp, bacs, phsu]
von Willebrand Factor [aapp, bacs, phsu]
Protein C [aapp, bacs, phsu]
Fibrin D-dimer [aapp, bacs]
Plasminogen [aapp, bacs, phsu]
Three [qnco]
Group [idcn]
conclude [bodm, orch]
Oral [spco]
Estrogen Replacement Therapy [topp]
Progesterone [horm, phsu, strd]
Result [ftcn]
Coagulation [ortf]
Activation [acty]
Increased [qnco]
fibrinolytic [topp]
Potential [qlco]
transdermal estrogen [horm, phsu, strd]
APPEAR [qlco]
effects [qlco]
Haemostasis [ortf]
Result [ftcn]
account [idcn]
Increased [qnco]
Risk [qlco]
Venous Thromboembolism [patf]
Users [humn]
Oral [spco]
postmenopausal [tmco]
Estrogen [horm, phsu, strd]
Potential [qlco]
ROUTE [ftcn]
Estrogen [horm, phsu, strd]
Administration [ocac]
prescribing [hlca]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
At risk [qlco]
High [qlco]
Disease [dsyn]
